Leading in minimally invasive therapies for arterial disease, venous disease and cancer.
Delivering Meaningful Innovation.
Advancing the Treatment of Arterial Disease.  We’ve built a strong portfolio of products to serve this market and are uniquely positioned to provide physicians and hospital systems with a full tool box of solutions to treat patients.
Venous Therapies. Our venous portfolio offers a category-leading breadth of venous technologies including: venous stents, endovenous chemical ablation, ultrasound assisted clot dissolution devices, mechanical thrombectomy, and imaging catheters.
Tumor-Tackling Technologies. Our interventional oncology portfolio includes embolization technologies, and ablation technologies, all designed to prevent growth and cause tumor necrosis.